Overview

Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy

Status:
Terminated

Trial end date:
2011-09-01

Target enrollment:

Participant gender:

Summary

- To assess the effect of a long-term treatment by Genotonorm on linear growth in children with short stature receiving steroid therapy - To assess the effect of a long term treatment with Genotonorm on bone mineralisation - To assess the effect of a long term treatment with Genotonorm on body composition

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Hormones